Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

8-Bromo-cGMP sodium

Copy Product Info
😃Good
Catalog No. T14064Cas No. 51116-01-9

8-Bromo-cGMP sodium is a PKG activator, a membrane-permeable analog of cGMP. 8-Bromo-cGMP sodium has pain-relieving and vasodilatory effects, significantly inhibits Ca2+ macroscopic currents, and inhibits high K+-stimulated insulin release.

8-Bromo-cGMP sodium

8-Bromo-cGMP sodium

Copy Product Info
😃Good
Purity: 99.45%
Catalog No. T14064Cas No. 51116-01-9
8-Bromo-cGMP sodium is a PKG activator, a membrane-permeable analog of cGMP. 8-Bromo-cGMP sodium has pain-relieving and vasodilatory effects, significantly inhibits Ca2+ macroscopic currents, and inhibits high K+-stimulated insulin release.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
2 mg$35In StockIn Stock
5 mg$55In StockIn Stock
10 mg$89In StockIn Stock
25 mg$162In StockIn Stock
50 mgPreferential6-8 weeks6-8 weeks
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
This molecule is a custom-made product. TargetMol has an excellent synthesis team with the experience and capability to provide you with cost-effective products.If you have any questions, please feel free to contact us. We are committed to serving you wholeheartedly.
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.45%
Appearance:Solid
Color:Yellow
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
8-Bromo-cGMP sodium is a PKG activator, a membrane-permeable analog of cGMP. 8-Bromo-cGMP sodium has pain-relieving and vasodilatory effects, significantly inhibits Ca2+ macroscopic currents, and inhibits high K+-stimulated insulin release.
In vitro
8-Bromo-cGMP sodium (1 µM-0.1 mM) can inhibit acetylcholine-induced increases in intracellular calcium concentrations.[1]
8-Bromo-cGMP sodium (1-100 μM; 16 h) induces the synthesis of HO-1 protein in a concentration-dependent fashion.[2]
8-Bromo-cGMP sodium (1-100 μM; 8 h) increases the resistance of LLC-PK1 cells to CsA toxicity in concentration-dependently.[2]
In vivo
8-Bromo-cGMP sodium (0.3, 1, 3 nM; intrathecal administration; 10 min before the test; male ICR mice) significantly increases tail-flick latency in Vincristine-treated mice to the levels observed in vehicle-treated naive mice in a dose-dependent manner.[3] Additionally, 8-Bromo-cGMP sodium (10 mg/kg; iv; single dose) induces vasodilator responses in WT littermates and eNOS-Tg mice in the C57BL/6 background (19-35 g).[4]
Chemical Properties
Molecular Weight446.09
FormulaC10H10BrN5NaO7P
Cas No.51116-01-9
SmilesBrC1=NC(C(N=C(N2)N)=O)=C2N1[C@H]3[C@@H]([C@@]4([H])[C@](COP([O-])(O4)=O)([H])O3)O.[Na+]
Relative Density.2.96 g/cm3
Storage & Solubility Information
StorageIn solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
H2O: 101 mg/mL (226.41 mM), Sonication is recommended.
Solution Preparation Table
H2O
1mg5mg10mg50mg
1 mM2.2417 mL11.2085 mL22.4170 mL112.0850 mL
5 mM0.4483 mL2.2417 mL4.4834 mL22.4170 mL
10 mM0.2242 mL1.1209 mL2.2417 mL11.2085 mL
20 mM0.1121 mL0.5604 mL1.1209 mL5.6043 mL
50 mM0.0448 mL0.2242 mL0.4483 mL2.2417 mL
100 mM0.0224 mL0.1121 mL0.2242 mL1.1209 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy 8-Bromo-cGMP sodium | purchase 8-Bromo-cGMP sodium | 8-Bromo-cGMP sodium cost | order 8-Bromo-cGMP sodium | 8-Bromo-cGMP sodium chemical structure | 8-Bromo-cGMP sodium in vivo | 8-Bromo-cGMP sodium in vitro | 8-Bromo-cGMP sodium formula | 8-Bromo-cGMP sodium molecular weight